Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
Holding BIVI?
Track your performance easily
BIVI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.04 - $58.20
Previous Close$3.11
Volume721.32K
Average Volume (3M)5.61M
Market Cap
$54.64M
Enterprise Value$38.95M
Total Cash (Recent Filing)$20.02M
Total Debt (Recent Filing)$3.72M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
May 13, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.70
Shares Outstanding17,768,174
10 Day Avg. Volume3,331,102
30 Day Avg. Volume5,612,276
Standard Deviation0.46
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.62
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVie News
PremiumCompany Announcements
BioVie Raises $3.24 Million in Direct Offering
PremiumCompany Announcements
BioVie Raises Capital Through Direct Stock Offering
PremiumCompany Announcements
BioVie Raises $6 Million in Strategic Funding
PremiumCompany Announcements
BioVie Announces $6 Million Stock Offering and PlacementOwnership Overview
10.18% Insiders
0.65% Mutual Funds
0.21% Other Institutional Investors
88.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BIVI FAQ
What was BioVie’s price range in the past 12 months?
BioVie lowest stock price was $1.04 and its highest was $58.20 in the past 12 months.
What is BioVie’s market cap?
Currently, no data Available
When is BioVie’s upcoming earnings report date?
BioVie’s upcoming earnings report date is May 13, 2024 which is 193 days ago.
How were BioVie’s earnings last quarter?
BioVie released its earnings results on Feb 14, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.055.
Is BioVie overvalued?
According to Wall Street analysts BioVie’s price is currently Overvalued.
Does BioVie pay dividends?
BioVie does not currently pay dividends.
What is BioVie’s EPS estimate?
BioVie’s EPS estimate is -$0.29.
How many shares outstanding does BioVie have?
BioVie has 17,768,173 shares outstanding.
What happened to BioVie’s price movement after its last earnings report?
BioVie reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went down -0.823%.
Which hedge fund is a major shareholder of BioVie?
Among the largest hedge funds holding BioVie’s share is Sheaff Brock Investment Advisors LLC. It holds BioVie’s shares valued at N/A.
---
BioVie Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BIVI Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 5.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 33.3%
Last 30 Days ▲ 33.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.83%
12-Months-Change
Fundamentals
Return on Equity
-236.52%
Trailing 12-Months
Asset Growth
-10.62%
Trailing 12-Months
Company Description
BioVie
BioVie, Inc. is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA.
---
BIVI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BIVI
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-19.30%
initiated a buy rating 5 months ago
Copying Ashok Kumar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -19.30% per trade.
---